Brain

Wearable Sensors Market to Reach $13.2 billion, Globally, by 2034 at 21.4% CAGR: Allied Market Research

The global wearable sensors market is experiencing rapid growth due to rise in integration of wearable sensors with smartphones and…

2 months ago

TEDCO’s Maryland Innovation Initiative Announces Recent Company Formation and Technology Assessment Awardees

Maryland Innovation Initiative awards more than $2 million across 14 projects COLUMBIA, Md., Nov. 10, 2025 /PRNewswire/ -- TEDCO, Maryland's…

2 months ago

Brainomix Recognized in Global Health Tech Competition for Its Innovative Brainomix 360 Stroke Technology

Company earns top recognition in the Science category for its stroke AI technology CHICAGO and OXFORD, England, Nov. 10, 2025…

2 months ago

Zenos Health Summit 2025 Concludes Transformative Three-Day Gathering of Global Longevity Leaders in Riyadh

Over 1,000 Global Leaders Convene for Inaugural Summit as Saudi Arabia Emerges as Hub for Wellness Innovation and Longevity Science…

2 months ago

Brain Balance Expands to Brooklyn, New York, Led by Veteran Educator and Advocate Sarah Weeks

NAPERVILLE, IL / ACCESS Newswire / November 10, 2025 / Brain Balance, a leading brain health and development program that…

2 months ago

CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting

HOUSTON, TX / ACCESS Newswire / November 10, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical…

2 months ago

Trillion-Dollar Digital Healthcare Transformations Shaped by AI, Quantum and Biotech Breakthroughs at GITEX GLOBAL

The world's largest tech and AI show brought groundbreaking innovations in healthcare, neurotech and life sciences to the forefront M42,…

2 months ago

Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations

- Simultaneously published in JAMA Cardiology along with moderated posters at AHA, acoramidis demonstrated: 59% risk reduction in ACM in…

2 months ago

MemoMaster Unveiled: How This Memo Master Cutting-Edge Brain Support Supplement Is Redefining Focus and Memory Health for the Digital Era

Boost memory, focus & mental clarity with MemoMaster – a clinically inspired brain supplement for sharper thinking, sustained energy &…

2 months ago

Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide

Results, presented at ObesityWeek® 2025, showed patients receiving NG101 saw 40% reduction in nausea incidence and 67% reduction in vomiting…

2 months ago